TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 54 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $22,108,000 | +1.7% | 22,235,000 | 0.0% | 0.34% | -23.0% |
| Q3 2020 | $21,742,000 | -36.1% | 22,235,000 | -36.0% | 0.45% | -47.2% |
| Q2 2020 | $34,018,000 | +5.7% | 34,735,000 | 0.0% | 0.85% | -43.6% |
| Q1 2020 | $32,172,000 | -98.6% | 34,735,000 | +43.3% | 1.50% | -60.4% |
| Q4 2019 | $2,314,443,000 | – | 24,235,000 | – | 3.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Southpaw Asset Management LP | 32,807,000 | $30,703,000 | 17.87% |
| INCOME RESEARCH & MANAGEMENT | 15,589,000 | $14,580,000 | 4.62% |
| Fore Capital, LLC | 6,000,000 | $5,642,000 | 1.73% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 69,885,000 | $65,625,000 | 1.35% |
| PICTET ASSET MANAGEMENT LTD | 13,500,000 | $296,010,000 | 0.63% |
| Bristol Advisors, LLC | 9,500 | $205,000 | 0.34% |
| Lombard Odier Asset Management (Europe) Ltd | 4,750,000 | $4,456,000 | 0.31% |
| AEGON USA Investment Management, LLC | 800,000 | $748,000 | 0.22% |
| OAKTREE CAPITAL MANAGEMENT LP | 16,755,000 | $15,756,000 | 0.21% |
| ZAZOVE ASSOCIATES LLC | 2,503,000 | $2,354,000 | 0.20% |